Refine by
Therapeutic Development Articles & Analysis
123 articles found
Neurotrophic factors are not only essential during development but continue to exert their effects in the adult nervous system. ...
This contextual behavior makes CCR1 a prime candidate for therapeutic modulation. Unlike receptors with highly selective ligand pools, CCR1’s redundancy ensures robustness of immune response but complicates therapeutic targeting. ...
Toward ELANE-Targeted Therapies The balance between ELANE's protective and pathogenic roles has prompted the development of ELANE inhibitors as therapeutic agents. Sivelestat, a small-molecule ELANE inhibitor, has shown promise in acute lung injury but is limited by specificity and bioavailability. ...
Primary podocyte cultures tend to proliferate for only a brief period, making it difficult to conduct long-term studies on their behavior or response to therapeutic agents. The development of immortalized human podocyte cell lines addresses this issue, providing continuously replicating cells that maintain functional characteristics similar to those found in ...
The ability to study these cells in a laboratory setting has been greatly enhanced through the development of immortalized human ovarian epithelial cell lines, particularly those that utilize the SV40 (Simian Virus 40) large T antigen. ...
Recombinant protein expression is a cornerstone of modern biopharmaceutical development, providing the means to produce proteins with therapeutic potential, enzymes, and antibodies. ...
This phenomenon is crucial in various contexts, including disease pathogenesis and the development of therapeutic interventions. For instance, when a vaccine elicits an immune response against a pathogen, it is vital to ensure that the generated antibodies do not target similar proteins in the body’s own tissues, as this could result in autoimmune ...
In cancer research, these vectors allow for the investigation of gene function and the potential development of gene therapies targeting tumor cells. In regenerative medicine, they have the capability to correct genetic disorders by delivering therapeutic genes to affected tissues. Moreover, in model organism studies, CRISPR/Cas9 lentiviral systems are employed ...
These protocols ensure that the AAVs supplied are not only effective but also safe for use in various experimental settings. Advancing Therapeutic Avenues Beyond basic research, optogenetics AAV production services hold significant promise for therapeutic applications. They provide a foundation for developing novel treatments for neurological ...
One of the key issues is drug resistance. Cancer cells often develop resistance to BCL2 inhibitors by upregulating other anti-apoptotic proteins like MCL1 or BCL-XL. ...
Additionally, the short half-life of chemokines in vivo and their potential to trigger off-target effects limit their therapeutic window. Another hurdle is the development of chemokine receptor antagonists. ...
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. ...
In recent years, the field of antibody drug design has become increasingly significant in the realm of therapeutic development, driven by the need for more effective and targeted treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. ...
Understanding the metabolic stability of potential drug candidates is paramount in the realm of pharmaceutical development. S9 metabolic stability assays provide critical insights into how a compound behaves within biological systems, especially concerning its metabolism, stability, and overall pharmacokinetics. ...
ADCs development services tackle this problem by delivering personalized therapeutic solutions designed to match the unique biological and molecular characteristics of different cancer types. ...
Autoimmune and Inflammatory Diseases: Cytokines are central to the development and progression of autoimmune and inflammatory diseases. Customized assays can help identify biomarkers and therapeutic targets. Drug Development: Evaluating the impact of new drugs on cytokine profiles is essential for assessing their efficacy and safety. ...
Furthermore, CAR T-cell therapy development services opened up new avenues for identifying therapeutic targets and formulating personalized therapies. Alfa Cytology employs state-of-the-art techniques including isolation, culture, engineering, expansion, and characterization of immune cells and stem cells to develop novel cell therapies. These ...
Preclinical drug discovery represents a critical phase in the development of new therapeutics. It is the process that bridges the gap between basic research and clinical testing, allowing for the evaluation of potential drug candidates in biological systems before they are tested in humans. ...
Alfa Cytology’s Ovarian Cancer Therapy Development Services aim to bridge this gap by offering highly customized, robust therapeutic solutions that correspond with ovarian tumors’ unique biological and molecular characteristics. ...
These services encompass the development of customized vaccines, therapeutic antibodies, cell therapies, etc. all undergoing rigorous quality control to ensure they fulfill the highest standards of efficacy and safety. In addition, the advent of diverse drug discovery solutions has unveiled immense possibilities for identifying novel ...